A physical mechanism to explain the delivery of chemical penetration enhancers into skin during transdermal sonophoresis - Insight into the observed synergism

The synergism between low-frequency sonophoresis (LFS) and chemical penetration enhancers (CPEs), especially surfactants, in transdermal enhancement has been investigated extensively since this phenomenon was first observed over a decade ago. In spite of the identifying that the origin of this syner...

Full description

Bibliographic Details
Main Authors: Polat, Baris E. (Contributor), Deen, William M. (Contributor), Langer, Robert (Contributor), Blankschtein, Daniel (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor)
Format: Article
Language:English
Published: Elsevier, 2015-10-13T18:52:27Z.
Subjects:
Online Access:Get fulltext
LEADER 02907 am a22002653u 4500
001 99235
042 |a dc 
100 1 0 |a Polat, Baris E.  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Chemical Engineering  |e contributor 
100 1 0 |a Polat, Baris E.  |e contributor 
100 1 0 |a Deen, William M.  |e contributor 
100 1 0 |a Langer, Robert  |e contributor 
100 1 0 |a Blankschtein, Daniel  |e contributor 
700 1 0 |a Deen, William M.  |e author 
700 1 0 |a Langer, Robert  |e author 
700 1 0 |a Blankschtein, Daniel  |e author 
245 0 0 |a A physical mechanism to explain the delivery of chemical penetration enhancers into skin during transdermal sonophoresis - Insight into the observed synergism 
260 |b Elsevier,   |c 2015-10-13T18:52:27Z. 
856 |z Get fulltext  |u http://hdl.handle.net/1721.1/99235 
520 |a The synergism between low-frequency sonophoresis (LFS) and chemical penetration enhancers (CPEs), especially surfactants, in transdermal enhancement has been investigated extensively since this phenomenon was first observed over a decade ago. In spite of the identifying that the origin of this synergism is the increased penetration and subsequent dispersion of CPEs in the skin in response to LFS treatment, to date, no mechanism has been directly proposed to explain how LFS induces the observed increased transport of CPEs. In this study, we propose a plausible physical mechanism by which the transport of all CPEs is expected to have significantly increased flux into the localized-transport regions (LTRs) of LFS-treated skin. Specifically, the collapse of acoustic cavitation microjets within LTRs induces a convective flux. In addition, because amphiphilic molecules preferentially adsorb onto the gas/water interface of cavitation bubbles, amphiphiles have an additional adsorptive flux. In this sense, the cavitation bubbles effectively act as carriers for amphiphilic molecules, delivering surfactants directly into the skin when they collapse at the skin surface as cavitation microjets. The flux equations derived for CPE delivery into the LTRs and non-LTRs during LFS treatment, compared to that for untreated skin, explain why the transport of all CPEs, and to an even greater extent amphiphilic CPEs, is increased during LFS treatment. The flux model is tested with a non-amphiphilic CPE (propylene glycol) and both nonionic and ionic amphiphilic CPEs (octyl glucoside and sodium lauryl sulfate, respectively), by measuring the flux of each CPE into untreated skin and the LTRs and non-LTRs of LFS-treated skin. The resulting data shows very good agreement with the proposed flux model. 
520 |a National Institutes of Health (U.S.) (Grant EB-00351) 
520 |a Massachusetts Institute of Technology. Institute for Soldier Nanotechnologies (Grant DAAD-19-02-D-002) 
546 |a en_US 
655 7 |a Article 
773 |t Journal of Controlled Release